Patent 11596613 was granted and assigned to University of Iowa Research Foundation on March, 2023 by the United States Patent and Trademark Office.
The invention provides compositions and methods to treat a hyperproliferative disorder with a GSH synthesis inhibitor and an anti-cancer composition.